Effectiveness of the 2014 european society of cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: A systematic review and meta-analysis

Authors :: O'Mahony, C. Akhtar, M.M. Anastasiou, Z. Guttmann, O.P. Vriesendorp, P.A. Michels, M. Magrì, D. Autore, C. Fernández, A. Ochoa, J.P. Leong, K.M.W. Varnava, A.M. Monserrat, L. Anastasakis, A. Garcia-Pavia, P. Rapezzi, C. Biagini, E. Gimeno, J.R. Limongelli, G. Omar, R.Z. Elliott, P.M.
Publication Year :: 2019
Abstract: Objective In 2014, the European Society of Cardiology (ESC) recommended the use of a novel risk prediction model (HCM Risk-SCD) to guide use of implantable cardioverter defibrillators (ICD) for the primary prevention of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM). We sought to determine the performance of HCM Risk-SCD by conducting a systematic review and meta-analysis of articles reporting on the prevalence of SCD within 5 years of evaluation in low, intermediate and high-risk patients as defined by the 2014 guidelines (predicted risk

Tools